Target intelligence / Profile preview

Family with sequence similarity 83 member C antisense RNA 1 (FAM83C-AS1)

Target
FAM83C-AS1
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript, Other (regulatory RNA)
01

Overview

FAM83C antisense RNA 1 (FAM83C-AS1) is a long non-coding antisense RNA that regulates gene expression through epigenetic mechanisms. It is notably upregulated in colorectal cancer, where it promotes tumor cell proliferation, migration, invasion, and stemness. Mechanistically, FAM83C-AS1 inhibits expression of the tumor suppressor Semaphorin 3F (SEMA3F) by enhancing H3K27me3 methylation at the SEMA3F promoter through stabilization of the methyltransferase EZH2, which is facilitated by recruitment of the deubiquitinase ZRANB1. In experimental models, knockdown of FAM83C-AS1 reduces tumor growth, metastasis, and EMT, highlighting its functional contribution to cancer progression and its potential as a therapeutic and biomarker target. Currently, no approved drugs directly target FAM83C-AS1, but antisense technologies and RNA interference are the main experimental approaches. FAM83C-AS1 is considered a valid molecular target in oncology research, with increasing evidence supporting its role in colorectal cancer and potentially other malignancies.

Other names
FAM83C-AS1dJ614O4.3
02

Mechanism of action

Silencing by RNA interference or antisense oligonucleotides is under investigation as a potential therapeutic strategy. Knockdown leads to suppression of tumor growth and metastasis in preclinical models. FAM83C-AS1 binds ZRANB1, increasing EZH2 stability. EZH2 catalyzes H3K27me3 methylation on SEMA3F promoter, suppressing SEMA3F. Reduced SEMA3F leads to enhanced colorectal cancer cell growth and invasiveness. Knockdown of FAM83C-AS1 reverses these effects.

03

Biological functions

Epigenetic regulationSuppression of gene expressionPromotion of cancer cell proliferationPromotion of invasion and metastasisMaintenance of cancer stemnessRegulation of epithelial-mesenchymal transition (EMT)
04

Disease associations

Cancer (specifically, colorectal cancer)Tumor progressionMetastasis
05

Biomarkers

High FAM83C-AS1 levels in tumor tissue (potential diagnostic/prognostic marker in colorectal cancer)Negative correlation with SEMA3F expressionCorrelation with markers of EMT and stemness (e.g., N-cadherin, CD133, CD44)

Beyond the preview

Go deeper on Family with sequence similarity 83 member C antisense RNA 1 (FAM83C-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 83 member C antisense RNA 1 (FAM83C-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call